What is AOD-9604? AOD-9604 is a synthetic peptide built from the C-terminal region of human growth hormone (hGH), corresponding to residues 176-191, with an added tyrosine at the N-terminus. It belongs to a class of research compounds known as growth-hormone fragments, and it has been studied in laboratory and preclinical models as a tool for exploring how a small piece of a large hormone can retain some of the parent molecule’s activity. This overview summarizes the peptide-chemistry concept behind AOD-9604 and what published research has actually examined, framed strictly for scientific and educational purposes.
What Is AOD-9604 at the Molecular Level
Human growth hormone is a 191-amino-acid protein with several distinct functional regions. Researchers have long been interested in whether individual domains of the hormone could be isolated to study specific activities in the absence of the full protein. AOD-9604 is one product of that line of investigation: it reproduces the C-terminal “lipolytic” domain of hGH rather than the whole molecule.
According to PubMed-indexed analytical work, AOD-9604 consists of the hGH fragment spanning amino acids 177-191 with an additional tyrosine residue at the N-terminus, and it has been characterized in serum and urine using mass-spectrometry methods (Cox et al., 2014, DOI). That same work identified several in vitro metabolites of the peptide, including a comparatively stable fragment, illustrating the kind of structural and stability questions that define much of the AOD-9604 literature.
The Growth-Hormone-Fragment Concept
The scientific rationale that motivated AOD-9604 research was the observation that the fat-metabolism-related (“lipolytic”) activity of growth hormone appeared to be associated with its C-terminus. The hypothesis under study was whether a short fragment could reproduce that particular activity while behaving differently from full-length hGH with respect to other effects, such as those on blood glucose. This is a mechanistic research question about structure-activity relationships, not a statement about outcomes in people.
In the broader context of drug development, AOD-9604 has been described in review literature as a human growth-hormone fragment investigated for effects on adipose-tissue metabolism, listed among various experimental agents that were undergoing evaluation at the time (Halford, 2006, PubMed). It is important to note that inclusion in such a review reflects investigational status during that period and does not establish efficacy or approval.
What Preclinical Research Has Examined
Most of the primary experimental data on AOD-9604 comes from animal models. In one frequently cited study, researchers administered hGH and AOD-9604 to obese mice and to beta-3-adrenergic-receptor knockout mice to probe the pathways involved in fat metabolism. The authors reported changes in body weight and body fat in the obese-mouse model and examined expression of the beta-3-adrenergic receptor, concluding that the observed lipolytic actions were not mediated directly through that receptor even though receptor expression changed (Heffernan et al., 2001, DOI). Findings of this type are specific to the animal models and experimental conditions used and cannot be extrapolated to other contexts.
Separately, AOD-9604 has been examined outside the metabolism setting. In a rabbit model of collagenase-induced knee osteoarthritis, investigators studied intra-articular injections of the peptide, alone or combined with hyaluronic acid, and reported effects on cartilage-degeneration scoring in that model (Kwon and Park, 2015, PubMed). This represents a distinct and preliminary research direction. As with the metabolic studies, these are animal-model observations, and the evidence base overall remains limited.
AOD-9604 in Analytical and Anti-Doping Research
A notable share of the peer-reviewed literature on AOD-9604 concerns detection science rather than physiology. Because the peptide is prohibited in sport, laboratories have developed and validated methods to identify it and its metabolites in biological samples (Cox et al., 2014, DOI). Related work examined whether the fragment interferes with established growth-hormone isoform immunoassays used in doping control, reporting that AOD-9604 did not influence that particular assay (Orlovius et al., 2013, DOI). These studies are valuable for understanding how the compound is characterized analytically in a laboratory setting.
Understanding the Evidence
Taken together, the published record on AOD-9604 is dominated by preclinical animal studies, analytical-chemistry method development, and review-level mentions. The mechanistic and detection literature is the strongest part of that record, while claims about broader physiological outcomes remain preliminary and model-dependent. For anyone building a working understanding of what AOD-9604 is, the most defensible summary is narrow: it is a defined C-terminal hGH fragment that has served as a subject of laboratory research into structure-activity relationships, lipid metabolism in animal models, and analytical detection.
References
- Heffernan M, Summers RJ, Thorburn A, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001. According to PubMed. https://doi.org/10.1210/endo.142.12.8522
- Halford JCG. Obesity drugs in clinical development. Curr Opin Investig Drugs. 2006. According to PubMed. https://pubmed.ncbi.nlm.nih.gov/16625817/
- Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D. Detection and in vitro metabolism of AOD9604. Drug Test Anal. 2014. According to PubMed. https://doi.org/10.1002/dta.1715
- Orlovius AK, Thomas A, Schänzer W, Thevis M. AOD-9604 does not influence the WADA hGH isoform immunoassay. Drug Test Anal. 2013. According to PubMed. https://doi.org/10.1002/dta.1557
- Kwon DR, Park GY. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. Ann Clin Lab Sci. 2015. According to PubMed. https://pubmed.ncbi.nlm.nih.gov/26275694/
Research Use Only. AOD-9604 and related compounds discussed here are intended solely for laboratory and scientific research. They are not drugs, dietary supplements, or articles for human or veterinary consumption, and nothing in this article is medical advice or a recommendation for use, dosing, or administration in humans or animals. Descriptions of published studies report what researchers investigated and do not constitute claims of safety or efficacy.